CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to advance cell therapy by developing imaging tools to track transplanted cells in real time. It focuses on improving understanding of cell therapy mechanisms and enhancing treatment safety across various disease areas, including cancer and neurological disorders.
Cell therapy can be defined as the transplantation of living cells for the treatment of medical disorders.
Three different principles underlie the increasing interest in cell therapy. 1.
Transplanted cells used as an “active drug” 2.
Transplanted cells used to replace damaged and degenerated tissue. 3.
Cells used as a drug delivery vehicle.
Promising results have been obtained in pre-clinical and clinical studies, however, success rates have been variable and clinical benefits have been limited.…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Rotterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Israel, Rehovot
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
